The three sites
Prescribing information for the injectable GLP-1 receptor agonists specifies the abdomen, thigh and upper arm. They are interchangeable for the purposes of the medication working.
| Site | Where | Practical notes |
|---|---|---|
| Abdomen | Anywhere on the belly outside roughly two inches around the navel | Largest area, easiest to see and reach, most consistent absorption. The usual default. |
| Front-outer thigh | The upper outer surface, between roughly a hand's width below the hip and above the knee | Easy self-access seated. Absorption is more affected by leg exercise than the other sites. |
| Back of upper arm | The fleshy area between shoulder and elbow | Often the least sensitive. Awkward to reach on your own dominant side. |
Does the site change how well it works?
It changes absorption rate slightly, because sites differ in blood supply — the abdomen is typically best perfused and therefore fastest. For a compound with a multi-day half-life, that difference is a small perturbation of a curve measured in days, and total absorption is affected far less than speed.
In practice this means switching sites will not make a weekly medication stop working, and it is not something to be anxious about. It also means the reverse: choosing a particular site is not a lever for improving results, and advice framed that way is overstating a small effect.
Why rotation matters more here than it seems
Repeated injection into the same small area causes the fat there to thicken — lipohypertrophy. The affected tissue is firm, usually painless, and often less sensitive than surrounding skin, which is the trap: the spot that hurts least is the spot you should be avoiding, so people drift toward it without realising.
Absorption from hypertrophied tissue is slower and more erratic. On a long-term weekly medication that shows up as unexplained variability — a week that feels different from the last for no apparent reason — and it is very rarely attributed to the injection site, because nobody is looking there.
The fix is unremarkable. Move at least an inch from the previous site, alternate sides, and work through the regions rather than settling on a favourite. Check by feel every few weeks: run your fingertips flat over each area and compare against the opposite side.
Pens and prefilled devices
Most approved GLP-1 products are supplied as pens, which changes the mechanics but none of the site logic. The needle is short and fine, and the device controls delivery, so the technique is largely: clean the site, let it dry, place the pen flat against the skin, and hold it in place for the full count specified in the instructions.
That count is the step most often shortened, and it is the one that matters — withdrawing early leaves part of the delivery on the skin rather than under it. If you see liquid at the site afterwards, the hold was too short rather than the injection being faulty.
Key takeaways
- Abdomen, thigh and upper arm are all appropriate; the abdomen is the easiest default.
- Site affects absorption speed slightly and total absorption very little — it is not a lever for better results.
- Fifty-odd injections a year into a few regions is why rotation matters more than it first appears.
- Hypertrophied tissue is less sensitive, so comfort quietly steers you toward the worst spot.
Stop keeping this in your head.
Pep AI keeps your compounds, vials, schedule, injection sites and history in one place — and does the reconstitution math for you. Free on iOS and Android.
Frequently asked questions
Keep reading
This guide is general information for people already organising their own protocol. It is not medical advice, it does not recommend any compound or dose, and Pep AI is not a medical device. Talk to a qualified healthcare professional about anything you inject.
Published by the Pep AI team · Updated August 2026